Biome Australia Ltd (AU:BIO) has released an update. Biome Australia Ltd has successfully identified and validated its new probiotic strain, Lactobacillus plantarum BMB18, marking a significant ...

Unlock your investing potential with TipRanks Premium - Now At 40% OFF! Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter Biome Australia Ltd has strengthened ...

Revenue: AU$18.4m (up 42% from FY 2024). Net income: AU$214.7k (up from AU$1.67m loss in FY 2024). Profit margin: 1.2% (up from net loss in FY 2024). The move to profitability was driven by higher ...

Here's why Bell Potter thinks this small-cap stock is a buy. The post The ASX small-cap stock that could double in value in ...

Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying, like in the case of Biome Australia Limited (ASX:BIO), it sends a favourable ...

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...

Biome Australia Ltd. engages in the research, development, manufacture, and distribution of evidence-based products linking the gut and human health. It offers live biotherapeutics products and ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Biome Australia Ltd ( (AU:BIO)) has ...

Bell Potter analyst Martyn Jacobs maintained a Buy rating on Biome Australia Ltd (BIO – Research Report) today and set a price target of A$0.85. The company’s shares closed today at A$0.52. According ...